Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8946292 | JAVELIN PHARMS INC | Formulations of low dose diclofenac and beta-cyclodextrin |
Mar, 2027
(4 years from now) |
Market Authorisation Date: 23 December, 2014
Treatment: Management of pain
Dosage: SOLUTION;INTRAVENOUS
6
United States
5
Korea, Republic of
3
Japan
3
European Union
2
Israel
2
China
1
Australia
1
Canada
1
Mexico
1
South Africa
1
Brazil
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9220784 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9132110 | HORIZON | Treatment of pain with topical diclofenac |
Oct, 2027
(4 years from now) | |
US9168305 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9066913 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9339551 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9339552 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9539335 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US8563613 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US8871809 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9101591 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US9168304 | HORIZON | Diclofenac topical formulation |
Oct, 2027
(4 years from now) | |
US8252838 | HORIZON | Diclofenac topical formulation |
Apr, 2028
(5 years from now) | |
US9415029 | HORIZON | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8618164 | HORIZON | Treatment of pain with topical diclofenac compounds |
Jul, 2029
(6 years from now) | |
US9375412 | HORIZON | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8217078 | HORIZON | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8741956 | HORIZON | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US9370501 | HORIZON | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8546450 | HORIZON | Treatment of pain with topical diclofenac compounds |
Aug, 2030
(7 years from now) |
Market Authorisation Date: 16 January, 2014
Treatment: Use of topical diclofenac for treating pain; Use of topical diclofenac sodium for treating pain; Use of topical diclofenac on a joint for treating osteoarthritis; Use of topical diclofenac on the knee and a second topical prescription medication on the same knee; Combination use of topical diclofenac on the knee and administration of an oral nsaid.; Use of topical diclofenac on the knee and a second topical agent selected from sunscreen and insect repellant
Dosage: SOLUTION;TOPICAL
31
United States
2
China
2
European Union
1
Hong Kong
1
Israel
1
New Zealand
1
Australia
1
Denmark
1
Russia
1
Canada
1
Mexico
1
South Africa
1
Japan
1
Brazil
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8618164 | NUVO PHARMS INC | Treatment of pain with topical diclofenac compounds |
Jul, 2029
(6 years from now) | |
US8741956 | NUVO PHARMS INC | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8217078 | NUVO PHARMS INC | Treatment of pain with topical diclofenac |
Jul, 2029
(6 years from now) | |
US8546450 | NUVO PHARMS INC | Treatment of pain with topical diclofenac compounds |
Aug, 2030
(7 years from now) |
Market Authorisation Date: 04 November, 2009
Treatment: Use of topical diclofenac on the knee and a second topical prescription medication on the same knee; Combination use of topical diclofenac on the knee and administration of an oral nsaid.; Use of topical diclofenac on the knee and a second topical medication on the same knee; Use of topical diclofenac on the knee and a second topical agent selected from sunscreen and insect repellant
Dosage: SOLUTION;TOPICAL
15
United States
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic